Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC SDZ 224-015 | 161511-45-1 | 96.1% | C30H35Cl2N3O9 | 25 MG
SDP

Catalog No. 5000357403
Encompass_Preferred

SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. It exhibits anti-COVID-19 activity by targeting Mpro (IC50 of 30 nM).

  • Orally active inhibitor of IL-1β converting enzyme and caspase-1
  • Exhibits anti-COVID-19 activity
  • Potently reduces carrageenin-induced paw oedema
  • Displays analgesic activity in the Randall-Selitto yeast-inflamed paw pressure test
  • For research use only

Catalog No. 50-003-57403 Supplier Medchemexpress LLC Supplier No. 25MGHY141622
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. It exhibits anti-COVID-19 activity by targeting Mpro (IC50 of 30 nM).

  • Orally active inhibitor of IL-1β converting enzyme and caspase-1
  • Exhibits anti-COVID-19 activity
  • Potently reduces carrageenin-induced paw oedema
  • Displays analgesic activity in the Randall-Selitto yeast-inflamed paw pressure test
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.